Stephen C Turner insider trades: Protea Biosciences Group (PRGB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stephen reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 25, 2016 | PRGB | ↑ Buy | 20,000 | $0.15 | $3K | Direct | Jul 27, 2016 (2d) |
| Jul 5, 2016 | PRGB | ↑ Buy | 24,000 | $0.15 | $4K | Direct | Jul 8, 2016 (3d) |
| Jul 30, 2013 | NONE | ↑ Buy | 224,204 | $112102.00 | $25.13B | Direct | Feb 13, 2014 (198d) |
| Jul 30, 2013 | NONE | ↑ Buy | 224,204 | $112102.00 | $25.13B | Jointly held with wife, Nancy Turner | Feb 13, 2014 (198d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Stephen C Turner's insider trades
Stephen C Turner is Chief Executive Officer at Protea Biosciences Group (PRGB). Since Jul 30, 2013, Stephen has reported 4 open-market purchases worth $50.27B and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (2 filings), grants and awards (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRGB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.